StreetAlpha.app
Home › Stocks › AORT

Artivion, Inc. (AORT)

Healthcare
$18.27
▼ −1.11%
LAST CLOSE · NOV 17

Artivion makes medical devices and human tissues for heart and aorta surgery, including stent grafts and heart valves. It last closed at $18.27 on Nov 17, down 1.11% on the day. AORT reports earnings on Thu, Feb 11, 2027. The average 12-month price target from 2 analysts is $36.00 (+97.0% from the last close), with a high of $42.00 and a low of $30.00. In the past 30 days there were 1 dark pool print totaling $621K, the largest $621K.

AI Auto Pilots
Is AORT in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$481.9M
+14.0% vs a year ago
Net income
−$17.6M
−3.7% margin
EPS (diluted)
−$0.36
Free cash flow
−$44.4M
−9.2% margin
Valuation
Market cap
$891.4M
48.8M shares
P/E
–
No P/E while losing money
Price to sales
1.8
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$48.4M
At Sep 30
Debt
$363.8M
At Sep 30
Shareholder equity
$446.4M
Shares outstanding
48.8M
At Oct 30
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $298.8M$298.8MFY2021FY2022: $313.8M$313.8MFY2022FY2023: $354.0M$354.0MFY2023FY2024: $388.5M$388.5MFY2024FY2025: $441.3M$441.3MFY2025

From AORT's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 6). Last 12 months adds up the four latest quarters.

Next report
Feb 11
2027 · Time not announced
Consensus EPS forecast
-$0.04
$123.6M revenue est.
Year-ago EPS
—
Not on file
Options-implied move
—
Posted about a week before
Analyst consensus
2 Buy
2 firms · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
2 Buy
2firms
2 Buy0 Hold0 Sell
Only 2 firms rated AORT in the past 90 days, not enough for a consensus
Average 12-month target
$36.00
▲ 97.0% upside

Based on 2 analysts who set a price target on AORT in the past 90 days. The average target is $36.00, with a high of $42.00 and a low of $30.00, compared with the last close of $18.27.

Low $30.00Avg $36.00High $42.00
Blue marker: last close $18.27
Highest target$42.00
Average target$36.00
Lowest target$30.00
Latest rating changes
Canaccord GenuityTarget lowered
Nov 6Buy$40 → $30
CitizensMaintained
Nov 6Buy$42
Canaccord GenuityTarget raised
Aug 18Buy$36 → $40
NeedhamReiterated
Jul 20Buy$44
Canaccord GenuityMaintained
Jun 16Buy$36
DateFirmActionRatingPrice target
Nov 6Canaccord GenuityTarget loweredBuy$40 → $30
Nov 6CitizensMaintainedBuy$42
Aug 18Canaccord GenuityTarget raisedBuy$36 → $40
Jul 20NeedhamReiteratedBuy$44
Jun 16Canaccord GenuityMaintainedBuy$36
Loading…

Technical Analysis

AORT · as of the Nov 17 close · updated after every close
Downtrend, nearing oversold

The stock is 21% below its 20 day and 24% below its 50 day average. It is 54% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 32), near oversold. The nearest support is the 52 week low at $18.11, and the nearest resistance the Pivot at $18.37.

Short trendBearish
Long trendBearish
MomentumWeak
StretchNear oversold
VolatilityHigh, 7.4%/day
Key levels
$48.2552 week high+164.1%
$28.12200 day average+53.9%
$24.35100 day average+33.3%
$22.6150 day average+23.8%
$22.12Swing high (Jun 17)+21.1%
$22.0320 day average+20.6%
$18.57Pivot R1+1.6%
$18.37Pivot+0.5%
$18.27Last close
$18.1152 week low−0.9%
$18.06Pivot S1−1.1%
Indicators
RSI (14)32.32Weak, oversold below 30Neutral
MACD-1.13Below its signal lineBearish
Stochastic2.5Near the bottom of its rangeOversold
ADX (14)24.3Weak trend
Williams %R-98.3Oversold below −80, overbought above −20Oversold
CCI (20)-131.1Oversold below −100, overbought above 100Oversold
Rate of change−23.0%Change over 10 sessionsBearish
ATR (14)$1.35Typical daily range, 7.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for AORT

What happened before

See how AORT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow AORT usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How AORT has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in AORT in the last 90 days.

Loading…

See today’s whale options flow across the market →

Dark Pool

30D
Prints
1
Notional
$621K
Largest print
$621K
Loading…

AORT Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Strongly bullish
Strongly bearishNeutralStrongly bullish
  • ▲126 buying vs 83 selling
  • ▲Held by funds +1.1 pts
  • ▲Funds holding +10
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding216206+4.9%
In funds' top 10220.0%
Held by funds96.1%95.0%+1.1 pts
New / increased41 / 8534 / 85+5.9%
Reduced / sold out52 / 3157 / 66−32.5%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See AORT institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether AORT is in one of them and how their past AORT trades turned out.

AORT in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered AORT in an article yet. Here's the latest on the wider market.

AORT Congress Trades

All congress trades →
Trades, 12 months
5
Buys
2
40%
Sells
3
60%
People
2
Last filed Sep 22
Who traded AORT · since 2022
Latest 5 filings of 14
$1K – $15KTraded Jul 29, 2026Filed Sep 22, 2026
$1K – $15KTraded Aug 20, 2026Filed Sep 11, 2026
$1K – $15KTraded Jul 16, 2026Filed Sep 4, 2026
$1K – $15KTraded May 15, 2026Filed Jul 1, 2026
Gilbert CisnerosSell (partial)
$1K – $15KTraded Oct 9, 2025Filed Nov 18, 2025
PersonTypeAmountTradedFiledDelay
Donald J TrumpExecutive branchSell$1K – $15KJul 29, 2026Sep 22, 202655 d
Gilbert CisnerosD · CABuy$1K – $15KAug 20, 2026Sep 11, 202622 d
Gilbert CisnerosD · CABuy$1K – $15KJul 16, 2026Sep 4, 202650 d
Donald J TrumpExecutive branchSell$1K – $15KMay 15, 2026Jul 1, 202647 d
Gilbert CisnerosD · CASell (partial)$1K – $15KOct 9, 2025Nov 18, 202540 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Artivion

Artivion is based in Kennesaw, Georgia, and makes medical devices and implantable human tissues for heart and aorta surgery. Its main product lines include aortic stent grafts, On-X mechanical heart valves, surgical sealants such as BioGlue, and processed human heart and vascular tissues. Its products are used mainly by cardiac and vascular surgeons and cardiologists to treat patients with aortic disease, such as heart valve disease and aneurysms. The company sells these products to hospitals and surgical teams around the world.

Headquarters
Kennesaw, GA
Founded
1984